ICON Strategic Solutions

ICON is proud to sponsor the ECNP Meeting on Precision Psychiatry taking place 20-21 January 2025 where experts will discuss the development and implementation of novel targeted therapies in psychiatry. Register to attend virtually by 20 January: https://ow.ly/6XpF50UATNO

Join us at the Disruptive Technology for Clinical Trials Europe on 28 January in London. Alexandre Malouvier, Senior Director Scientific Affairs & Digital Innovation, will share insights on the potential for AI in clinical research and how to navigate implementation hurdles at 1.10pm. Register today: https://ow.ly/ni9H50UCA9Z

ICON’s findings show nearly half (49%) of survey respondents believe personalised therapies will be oncology’s focus moving forward. Explore new industry data and uncover the trends and challenges in the current cancer treatment landscape in the article: https://ow.ly/j1aJ50UBK1w

We’re proud to share our ICON team in Mexico’s collaboration with TECHO – Un Techo para mi País, an organisation providing safe, dignified housing for families in need. Through this ICON4U Social Responsibility initiative, collaborators helped build two homes in the Paxia (Los Reyes la Paz) community near Mexico City, offering shelter and a fresh start for two families. Thank you to everyone involved for your hard work and dedication. Together, we’re creating lasting change and making a meaningful impact. If you would like to read more about joining ICON in LATAM please follow the link: https://ow.ly/jNll50UCN3O

At first glance, translating clinical outcome assessments (COAs) from their original language to other languages appears to be no more complicated than other trial planning elements. However, as scientific instruments, the process is much more complex. Read our new article in PM LiVE and find out which factors need to be considered during the #COA translation process. https://ow.ly/MqFM50UBCgW

At first glance, translating clinical outcome assessments (COAs) from their original language to other languages appears to be no more complicated than other trial planning elements. However, as scientific instruments, the process is much more complex. Read our new article in PM LiVE and find out which factors need to be considered during the #COA translation process. https://ow.ly/AH5T50UBCgX

What does it take to lead in the ever-evolving world of clinical data science? Stephen Cameron, Director of Clinical Data Science at ICON, shares his journey, insights, and the skills that matter most in this fascinating field. Whether you’re curious about clinical data science or considering your next career move, Stephen’s story offers a wealth of inspiration and practical advice. https://ow.ly/iixG50UAVMJ

ICON is a proud sponsor of the ECNP Meeting on Precision Psychiatry taking place 20-21 January 2025 in Frankfurt, Germany. This event brings together experts from all stakeholders to discuss the challenges and opportunities associated with making precision psychiatry a practical reality. Register to attend virtually by 20 January: https://ow.ly/kcgk50UATMi

Regulators expect sponsors to protect patient privacy while sharing data that is transparent enough to be useful to researchers. As EMA Policy 0070 expands its remit in 2025, our blog outlines ways that sponsors can meet the expectations of regulators, patients and researchers. https://ow.ly/en8Z50Uo42e

Imaging biomarkers are an essential part of measuring the efficacy of potential new treatments in oncology studies. However, the methods of measuring tumour growth have not changed much since the RECIST protocol was developed in 2000. This article compares the use of imaging biomarker methodologies such as RECIST 1.1 with novel tumour growth rate (TGR) modelling, looking at both the advantages and considerations for using TGR modelling within oncology research. https://ow.ly/8we450UzfYC